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Percutaneous Transluminal Angioplasty of a Totally Occluded Venous 
Bypass Graft: A Challenge That Should Be Resisted 
Pim J. de Feyter, MD, Patrick Serruys, MD, Marcel van den Brand, MD, Hannie Meester, 
Kevin Beatt, MD, and Harry Suryapranata, MD 
P ercutaneous transluminal angioplasty is an accept- ed treatment for stenoses of bypass graft& and for 
total coronary artery occlusions.3-5 It follows that the 
same treatment would also be appropriate for total occlu- 
sions of saphenous aortocoronary bypass grafts. This re- 
port describes our clinical experience with attempted i- 
latation of totally occluded saphenous bypass grafts. 
Of the 2,679 consecutive patients referred for percu- 
taneous transluminal coronary angioplasty at the Tho- 
raxcenter, Rotterdam, between September 1980 and De- 
cember 1988,96patients underwent percutaneous trans- 
luminal angioplasty of an obstruction in a saphenous 
aorta coronary bypass graft. This report describes the 
outcome of attempted angioplasty in 15patients, 12 men 
and 3 women, who presented with total occlusion of a 
venous bypass graft. The baseline clinical characteristics 
are listed in Table I. The mean age was 57 f 9 years 
(range 42 to 73). Most patients had significant narrow- 
ings in 3 major coronary arteries. 
Eleven patients received an aortocoronary circular 
sequential saphenous vein bypass graft. The number of 
anastomoses rangedfrom 2 to d/patient (mean 4 f 1). A 
proximal occlusion was located between the connection 
of the aorta and the first anastomosis, a midocclusion 
was located after the first anastomosis and before the 
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most distal anastomosis, and a distal anastomosis was 
located in the distal part of the graft. Single grafts were 
placed in the other 4patients (1 to 3/patient). The mean 
period between bypass surgery and angioplasty was 5.9 
f 4 years (range 0.25 to 12). The estimated uration of 
graft occlusion varied between 3and 6 months except for 
patients who presented with acute myocardial infarction. 
Angioplasty was attempted by the femoral approach 
in all patients. In 3 patients a balloon catheter with a 
fixedflexible guidewire at the tip (Schneider-Medintag) 
was used according to the technique described by Griint- 
zig. In the remaining 12 patients a guidewire was used to 
cross the lesion, then the balloon catheter was advanced 
across the stenosis and a series of 3 to 17 balloon injla- 
tions (mean 7 f 4) were carried out at pressures varying 
from 2 to 14 atmospheres (mean 11 f 3). The total 
inflation time variedfrom 15.5 to 970 seconds (mean 423 
f 280). The maximal balloon size used varied from 2.0 
to 4.2 mm (mean 3.0 f 1). A procedure was considered 
successful if (1) the total occlusion was reduced to a 
luminal narrowing <JO%; (2) no major complication 
occurred (myocardial infarction, death or acute sur- 
gery); and (3) there was no recurrence of reocclusion 
during hospitalization. Data are expressed as mean f 1 
standard deviation. 
In 1 patient the lesion could not be crossed with the 
wire. In the remaining 14 patients it proved relatively 
easy to perforate and cross the total occlusion with the 
wire and the balloon. However, in 4 patients the stenosis 
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TABLE I Clinical Characteristics and Outcome of Percutaneous Transluminal Angioplasty of Totally Occluded Saphenous 
Aortocoronary Bypass Grafts 
Age b-3. 
Pt sex 
No. 
CAD Interval 
Angina1 50% CABG- 
Status Luminal PTA 
(NYHA) Diameter (yrs) 
Type Angio- 
of Site of STK graphic 
Graft Occlusion II3 Success Complication 
Angiographic 
Reocclusion 
WW 
1 52,M II 3 6 Jump Distal - - - 
2 70. M II 3 12 Single Proximal - + Embolus/AMI/CK (684 IU) + (1) 
3 42,M Ill 3 5 Jump Proximal - + - f (4) 
4 58,M Ill 3 12 Single Proximal t t - t (0.2) 
5 46,M III 3 1.2 Jump Middle + t - + (1) 
6 59,M III 3 0.5 Jump Proximal - - - 
7 45,M III 3 0.25 Jump Distal - - Wire not crossed 
8 71,F Ill 3 8 Jump Middle - t - - (25) 
9 68,F III 2 9 Single Proximal - t Embolus, AMI/CK (280 IU) + (0.2) 
10 73, M III 3 1 Jump Proximal - - - 
11 57,M IV 2 8.5 Jump Middle t - Embolus/AMI/Shock/IABP/CK 
UC@ IU) 
12 61.F IV 3 10 Single Proximal t t Embolus/AMI/CK (so0 IU) + (8) 
13 55, M IV 3 3.5 Jump Middle - - Embolus/AMI/CK (148 IU) 
14 6O.M AMI 2 5.5 Jump Middle - t Embolus/AMI/CK (2,875 IU) + (0.2) 
15 54.M AMI 1 9 Jump Middle + t CK (900 IU) t AMI (12) 
AMI = acute myocardial infarction; CABG = coronary artery bypass grafting CAD = coronary artery disease; CK = aeatine khse (normal value = 100 U); PTA = percutaneous 
transluminal an&plastyj Jump = aortocoronary circular sequential saphenous vein bypass graft, NYHA = New York Heart Association; sinae = single aortocoronary venous graft; 
STK IB = strept&nase mtra-byws. 
was undilatable due to immediate ‘>ollapse” of the ste- 
nosis even after repeated dilatations with oversized bal- 
loons. The procedure was initially successful in 4 pa- 
tients (27%), but angiographically proven early reocclu- 
sion occurred in 2 of these patients and 1 patient 
developed a new reinfarction in the same myocardial 
territory of the previously dilated graft. 
In 5 patients, following clot formation, streptokinase 
(500,000 to 750,000 u) was infused into the graft during 
the procedure in an attempt to maintain patency. How- 
ever, this did not prevent early reocclusion in these pa- 
tients. Embolization with subsequent myocardial necro- 
sis occurred in 6 patients. Due to the negative results in 
the previous patients, we tried in patient 15 (the last one 
in our series) to prevent reocclusion with the implanta- 
tion of 2 stents. Although the initial result was accept- 
able (except for a distal embolus) and despite intensive 
anticoagulant treatment, the graft was totally occluded 
the following day (Figure I). Thus, an initial and long- 
term success was achieved in only 1 of the 15 patients. 
The short- and long-term results could not be related to 
the status of the native coronary arteries (diffuse sclerot- 
ic disease, proximal occlusion), collateral flow to the 
target artery or ventricular myocardium subserved by 
the graft (normal, hypokinetic or akinetic). 
Although coronary artery bypass grafting is highly 
successful in the relief of angina pectoris in patients with 
coronary artery disease, autogenous saphenous vein 
grafts undergo varying degrees of intimal proliferative or 
other degenerative changes with subsequent recurrent 
angina pectoris. The attrition rate at 1 year is approxi- 
mately 15% and it increases over the years. At the end of 
10 years, slightly more than half of the vein grafts are 
occluded (as shown by angiography) and, of those that 
remain open, about half show evidence of vein graft ath- 
erosclerosis.6*7 
This implies a substantial number of patients with 
totally occluded grafts who would be potential candidates 
for revascularization. Although reoperation can be per- 
formed with satisfactory results, the technical difficulty, 
morbidity, mortality and complications for a second and 
subsequent procedure are more frequent.* 
Therefore, percutaneous transluminal angioplasty is 
potentially an attractive alternative to repeat surgery. 
Only scant reported information is available about angio- 
plasty of totally occluded bypass grafts.2,6v9 Finci et al9 
described a patient who underwent a successful proce- 
dure, but follow-up data are lacking. In our experience, it 
was surprisingly easy to perforate and cross the total 
occlusion with the wire and the balloon. This suggests 
that the occlusions consist of rather loosely organized 
material, which can be easily traversed but which also 
tends to “collapse.” This explains why the lesion was 
“undilatable” in 4 patients. There is also an increased risk 
of thromboembolism during passage with the balloon 
catheter, which occurred in 6 of the 15 patients in our 
study and which has also been noted by others.lO 
This risk is probably increased because atherosclerosis 
in vein grafts tends to involve dilated segments and to be 
more friable and less fibrocalcific than the counterpart in 
the native coronary arteries. Therefore, the grafts are 
particularly vulnerable to disruption and to embolization 
of relatively large fragments. This is similar to the in- 
creased risk of perioperative myocardial infarction 
caused by atheroembolization during repeat coronary ar- 
tery bypass urgery. 
The early reocclusion after an angiographic successful 
dilatation that occurred in nearly all patients and the 
early “collapse” suggest rethrombosis rather than intimal 
fibrccellular proliferation or progressive atherosclerosis 
as the cause. In 1 patient, the implantation of stents also 
failed to prevent early reocclusion. The high frequency 
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of early reocclusion is probably related to the lack of 
a normal endothelium within these severely diseased 
graftsI 
Thus, although angioplasty of a totally occluded sa- 
phenoui vein graft is challenging, the outcome is so poor 
that the temptation to dilate should be resisted. The result 
may well be different for occlusions in grafts not older 
than 1 month because in such cases the occlusion almost 
always is due to thrombosis and usually is related to 
technical factors, such as anastomotic narrowing or oper- 
ative trauma to vein graft. 
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Effect of a Media Campaign on Delay Times and Ambulance Use 
in Suspected Acute Myocardial Infarction 
Johan Herlitz, MD, Marianne Hartford, MD, Marianne Blohm, RN, Bjdrn W. Karlson, MD, 
Lars EkstrOm, MD, Martin Risenfors, MD, Bertil Wennerblom, MD, Russell V. Luepker, MD, 
and Stig Holmberg, MD 
1 he early phase in suspected acute myocardial infaro tion (AMI) is particularly critical. More than 50% of 
deaths from coronary artery disease occur outside the 
hospital mainly due to ventricular fibrillation.’ Recent 
experiences strongly indicate that early intervention with 
thrombolysis2-4 and /I blocker@ can limit myocardial 
damage and thereby improve prognosis. Delay times in 
suspected AM1 have remained stable over the years. 
Therefore, a media campaign was started in the urban 
area of Giiteborg, Sweden, with the intention to shorten 
delay times and to increase ambulance use in patients 
with suspected AMI. 
Between February l&1986, and November 9,1987, 
allpatients presenting with chest pain or other symptoms 
suggestive of AMI at the emergency room of the Sahl- 
grenska Hospital lin Giiteborg were evaluated by emer- 
gency room physicians who used a specified protocol. 
Patients were prospectively classified into 4 categories in 
the emergency room according to the following dej%- 
lions: (I) obvious AMI, defined as typical symptoms and 
changes of ST-segment elevation with or without Q 
waves in the initial 12-lead electrocardiogram; (2) 
strong suspicion of AMI, including either (a) typical 
symptoms but an inconclusive lectrocardiogram, (b) 
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TABLE I Number of Patients Arriving Daily in the Emergency 
Room Due to Chest Pain, Before and During the First Four 
Months of the Campaign 
First Second Third Fourth 
Before Month Month Month Month 
All patients 11.3 19.6 13.1 12.4 13.8 
Category 
1 0.4 0.4 0.3 0.3 0.3 
2 2.3 2.7 2.1 2.1 2.5 
3 4.0 6.3 4.9 4.2 4.2 
4 4.6 10.2 5.8 5.8 6.9 
Patients with AMP 1.5 1.8 1.9 1.2 1.6 
‘BW3dOVlthefiMl&@OSiS. 
sudden onset of severe congestive heart failure with in- 
conclusive electrocardiogram, (c) atypical symptom 
but ST changes or Q waves on the electrocardiogram or 
(d) unstable angina pectoris; (3) vague suspicion of AMZ 
defined as atypical pain and no changes in the electrocar- 
diogram: and (4) no suspicion of AMI, indicated by (a) 
noncardiac diagnosis, (b) nonischemic cardiac diagnosis 
or (c) stable angina pectoris. 
In all admittedpatients, the delay time between onset 
of symptoms and arrival at hospital was recorded. All 
the patients in this population participated in a prospec- 
tive study presented elsewhere.7 
AMI was defined if 2 of the following criteria were 
fulj?lled: (1) chestpain with a duration >lS minutex(2) 
elevated serum aspartate aminotransferase and creatine 
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